Search
Browse
Statistics
Feeds

Clonally expanded effector CD4+ cytotoxic T lymphocytes are associated with severe neurological adverse events after immune checkpoint inhibitor therapy

Item Type:Dataset
Title:Clonally expanded effector CD4+ cytotoxic T lymphocytes are associated with severe neurological adverse events after immune checkpoint inhibitor therapy
Creators Name:Maschmeyer, P., Giguelay, A.M. and Ludwig, L.S.
Abstract:Immune checkpoint inhibitor (ICI) therapies present a pillar of modern cancer therapy but can cause severe and potentially fatal neurological immune-related adverse events (n-irAEs). Here, we performed single-cell RNA sequencing and T cell receptor profiling of PBMCs of a cohort of 17 cancer patients receiving ICI therapy. Our data suggest alterations in regulatory T cell frequencies and B cell states, and a significant enrichment of clonally expanded CD4+ cytotoxic T lymphocytes (CD4+ CTLs) with an effector gene expression profile in n-irAE patients.
Source:Gene Expression Omnibus (GEO)
Publisher:National Center for Biotechnology Information (NCBI)
Date:3 December 2025
External Fulltext:View full text on external repository or document server
Related to:

Repository Staff Only: item control page

Open Access
MDC Library